Harrow Health Inc (HROW)

Harrow Health Inc (HROW) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.1B; returns 1 day +1.0%, 1 week +4.3%, 1 year -27.2%.

Harrow, Inc. (formerly Harrow Health, Inc.) is a North American ophthalmic pharmaceutical company primarily engaged in the discovery, development, and commercialization of innovative prescription and non-prescription pharmaceutical products for a wide range of eye conditions, including dry eye disease, glaucoma, post-operative inflammation, allergies, and infections.

Groups HROW belongs to

• Shrinking Share Count
• Ophthalmology
• Pharmaceuticals
• Healthcare
• Commercial Stage
• Healthcare Services
• Vertical Integration
• Life Sciences

HROW financial model: income statement, cash flow and balance sheet